Registered Nurse Clinical Research
Resume:
CURRICULUM VITAE Melanie H. Drummond
Date of Preparation: October 11, 2011
GENERAL INFORMATION
PERSONAL DATA:
Address: ***** ******* ******
San Antonio, TX 78230
Phone Number: 210-***-****
Email Address: gg0xa2@r.postjobfree.com
EDUCATION:
Year Degree Institution
1977 B.S.N. Indiana University,
Bloomington, Indiana
WORK EXPERIENCE:
09/2010-10/2011 Clinical Research Coordinator Alamo Clinical Research Associates
Details: Coordinates all aspects of clinical research: Patient recruitment, regulatory documents, IRB correspondence, conducting clinical visits, obtaining and processing lab specimens, maintaining and dispensing of investigational product, data entry, corresponding with sponsors
06/2003-08/2010 Cystic Fibrosis Pediatric Clinic Coordinator CHRISTUS Santa Rosa Children’s Hospital
Details: Collaborates with multidisciplinary team to coordinate and manage care of children and families at the CHRISTUS Santa Rosa Pediatric Cystic Fibrosis Center. Research Coordinator for the CHRISTUS Santa Rosa Cystic Fibrosis Center.
11/1998 -06/2003 Research Nurse University of Texas Health Science Center at San Antonio,
Departments of Ophthalmology, Pediatrics (Neonatology and Gastroenterology)
Details: Worked as a research nurse in the above listed departments. Research coordinator for studies in Ophthalmology and Gastroenterology. Data collection for a high risk infant program in neonatology.
Work History Previous to 1998 available upon request
CERTIFICATION AND LICENSURE State Date Number Renewal Date Registered Nurse Indiana 7/1977 expired, non- renewed Registered Nurse Texas 8/197*-****** 8/2013
Certified Clinical Research Coordinator 03/201*-******-**/2013
BLS Certification- 07/2011 n/a 07/2013
American Heart
Association
PROFESSIONAL DEVELOPMENT:
Clinical
Date Description C.E.
Units/Hours.
01/30/2007 – 02/02/2007 Initiative for Pediatric Palliative Care Regional Retreat, 0.00/0.00
Sponsored by UTHSCSA, Department of Pediatrics,
Austin, Texas
Other
Date Description C.E.
Units/Hours.
10/22/2008 – 10/25/2008 22nd Annual North American Cystic Fibrosis Conference 30.00/0.00
2008, Orlando, Florida
10/03/2007 – 10/06/2007 21st Annual North American Cystic Fibrosis Conference 32.00/0.00
2007, Anaheim, California
11/02/2006 – 11/05/2006 20th Annual North American Cystic fibrosis Conference 30.00/0.00
2006, Denver, Colorado
10/20/2005 – 10/22/2005 19th Annual North American Cystic Fibrosis Conference 24.00/0.00
2005, Baltimore, Maryland
10/14/2004 – 10/17/2004 18th Annual North American Cystic Fibrosis Conference 28.00/0.00
Saint Louis, Missouri
10/16/2003 – 10/19/2003 17th Annual north American Cystic Fibrosis Conference 28.00/0.00
Research
Date Description C.E.
Units/Hours.
07/16/2007 – 10/04/10 CITI Program Course, Completed The Protection of 0.00/4.00
Human Research Subjects Course, UTHSCSA
Biomedical Research Group, requirement
02/13/2007 – 02/14/2007 Conducting Clinical Research Seminar, UTHSCSA, 0.00/14.00
Office of Clinical Research
10/3/2006 – 10/3/2006 Drug Information Association, Clinical Investigator 3.50/0.00
Module 1: Study Preparation and Initiation
11/1/2006 – 11/1/2006 Introduction to CF Clinical Research, 0.00/9.00
Denver, Colorado
11/3/2006 – 11/3/2006 Drug Information Association, Clinical Investigator 2.25/0.00
Module 2: Conducting the Study
RESEARCH
PROJECTS
Clinical Trials
01/2011 –10/2011 GlaxoSmithKline, HZC113782: A Clinical Outcomes Study to compare the effect of Fluticasone Furoate/Vilanterol Inhalation Powder 100/25mcg with placebo on Survival in Subjects with moderate Chronic Obstructive Pulmonary Disease (COPD) and a history of or at increased risk for cardiovascular disease. Alamo Clinical Research
01/2011-10/2011 A Phase 3, Open-Label, Randomized Trial to Evaluate the Safety and Efficacy of MP-376 Inhalation Solution( Aeroquin™) versus Tobramycin Inhalation Solution (TIS) in Stable Cystic Fibrosis Patients
09/2010 –08/2011 Muti-center, randomized, evaluator-blind, active-controlled, parallel-group design to determine safety, tolerability, and efficacy of multiple daily administration of LFF571 for 10 days in patients with moderate Clostridium difficile infections, Phase II Alamo Clinical Research
09/2010 – 10/2011 A Phase 3, Multicenter, Multinational, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MP-376 (Levofloxacin Inhalation Solution; Aeroquin™) in Stable Cystic Fibrosis Patients Alamo Clinical Research
09/2010 –12/2010 A Randomized, Multicenter, Double-Blind, Parallel-Group Trial to Assess the Analgesic Efficacy and Safety of a New Analgesic Compared with Placebo in Subjects with Painful Diabetic Peripheral Neuropathy, Phase IIb Alamo Clinical Research
11/2009 – 08/2010 Long Term Administration of Inhaled Mannitol in Cystic Fibrosis – A Safety and Efficacy Study, UTHSCSA, Department of Pediatrics
08/2007 – 08/2009 A Randomized, Open-label, Multicenter, Phase 3 Trial to Assess the Safety of Tobramycin
Inhalation Powder Compared to TOBI® in Cystic Fibrosis Subjects, UTHSCSA, Department of
Pediatrics
01/2007 – 06/2008 Antimicrobial Resistance in Sputum, Obtained from patients with Cystic Fibrosis, UTHSCSA, Department of Pediatrics
02/2006 – 08/2008 A Multicenter, Double-Blind Placebo-Controlled Randomized, Efficacy and Safety Study of
Denufosol Tetrasodium (INS372171) Inhalation Solution in Patients with Mild Cystic
Fibrosis Lung Disease, UTHSCSA, Department of Pediatrics
06/2000- 07/2006 A Multicenter Trial of Early Treatment for Retinopathy of Prematurity , UTHSCSA, Department of Ophthalmology
06/1999-04/2000 A Research Protocol Evaluating the Combination of Intron A and Ribavirin for the Treatment of Chronic Hepatitis C in Children , UTHSCSA, Department of Pediatrics
05/1986-05/1988 Evaluation of Prophylactic Passive Immunization Using Gammagard to Prevent Late Onset Neonatal Infection Among Low Birth Weight ( 1750 grams) Neonates, UTHSCSA, Department of Pediatrics
Collaborative Research
06/2003 – 12/2005 The Epidemiologic Study of Cystic Fibrosis, Study Coordinator
06/2003 – 08/2010 The North American Cystic Fibrosis Patient Registry, Study Coordinator
PUBLICATIONS:
Abstract
Willey-Courand DB, Inscore SC, Hentschel-Franks KA, Mendoza P., Drummond M., Branstetter A.. Improving the Nutritional Status of Pediatric Patients at CHRISTUS Santa Rosa Children’s Hospital Cystic Fibrosis Center 2005. p. 342 (Pediatric Pulmonology; vol. Suppl, no. 28).
Early Treatment for Retinopathy of Prematurity Cooperative Group, Revised Indications for the Treatment of Retinopathy of Prematurity, Results of the Early Treatment for Retinopathy of Prematurity Randomized Trial, , p. 1684 (Arch Ophthalmology;, vol. 121 Dec 2003)
Early Treatment of Retinopathy Cooperative Group, The Incidence and Course of Retinopathy of Prematurity: Findings from the Early Treatment of Retinopathy of Prematurity Study. (Pediatrics; Vol. 116 No. 1 July 2005, p. 15)
PRESENTATIONS:
09/2008 and 09/2009 CF Related Diabetes, Continuing Education Day in Cystic Fibrosis, Nurses and Respiratory Therapists, CHRISTUS Santa Rosa Children’s Hospital, San Antonio, TX
10/2005 Improving the Nutritional Status of Pediatric Patients at CHRISTUS Santa Rosa Children’s Hospital Cystic Fibrosis Center, 19th Annual North American Cystic Fibrosis Conference, Baltimore, MD
Details: Poster presented – Authors: Willey-Courand D, Inscore S, Hentschel-Franks K, Mendoza P, Drummond M, Branstetter A.
02/2003 Normal Growth and Development of 1 to 2 Year Olds. Red flags Indicating Developmental Delay, Retinopathy of Prematurity Technical Group Meeting, Phoenix, AZ.
02/2002 Developmental Follow-Up of Preterm Infants at Six and Nine Months, Retinopathy of Prematurity Technical Group Meeting, Atlanta, GA. February 2002.
Contact this candidate